Cellular mechanisms that mediate steatohepatitis, an increasingly prevalent condition in the Western world for which no therapies are available 1 , are poorly understood. Despite the fact that its synthetic agonists induce fatty liver, the liver X receptor (LXR) transcription factor remains a target of interest because of its anti-atherogenic, cholesterol removal, and anti-inflammatory activities. Here we show that tetratricopeptide repeat domain protein 39B (Ttc39b, C9orf52) (T39), a high-density lipoprotein gene discovered in human genome-wide association studies 2 , promotes the ubiquitination and degradation of LXR. Chow-fed mice lacking T39 (T39 −/− ) display increased high-density lipoprotein cholesterol levels associated with increased enterocyte ATP-binding cassette transporter A1 (Abca1) expression and increased LXR protein without change in LXR messenger RNA. When challenged with a high fat/high cholesterol/bile salt diet, T39 −/− mice or mice with hepatocytespecific T39 deficiency show increased hepatic LXR protein and target gene expression, and unexpectedly protection from steatohepatitis and death. Mice fed a Western-type diet and lacking low-density lipoprotein receptor (Ldlr −/− T39 −/− ) show decreased fatty liver, increased high-density lipoprotein, decreased low-density lipoprotein, and reduced atherosclerosis. In addition to increasing hepatic Abcg5/8 expression and limiting dietary cholesterol absorption, T39 deficiency inhibits hepatic sterol regulatory elementbinding protein 1 (SREBP-1, ADD1) 
and triglyceride levels were unchanged (data not shown). T39 −/− mice challenged with 3 weeks of the high fat/high cholesterol/bile salt (HF/HC/BS) diet had a 42% increase in HDL cholesterol levels (Extended Data Fig. 2a ), a 45% increase in apolipoprotein A-1 (ApoA-1), the major protein component of HDL particles (Extended Data Fig. 2b ), decreased very low-density lipoprotein (VLDL)/chylomicron cholesterol levels (Extended Data Fig. 2c ), and no difference in plasma triglyceride levels (data not shown). Gene expression microarrays of the liver of chow-fed T39 −/− and WT mice showed no significant differences in genes potentially involved in the regulation of HDL, including Apoa1, scavenger receptor b1, hepatic lipase, and Abca1, which accounts for over 90% of HDL formation 4 (data not shown).
There is longstanding evidence that the intestine makes a substantial contribution to the production of HDL 5, 6 . Small intestinal enterocytes from chow-fed T39 −/− mice showed increased Abca1 mRNA and protein (Extended Data Fig. 2d , e and Fig. 1a ). Protein levels of both isoforms of LXR, the major transcriptional activator of Abca1 (ref. 7) , were dramatically increased ( Fig. 1a and Extended Data Fig. 2e ), while Lxrα (Nr1h3, RLD1) and Lxrβ (Nr1h2, UR) mRNA levels were unchanged (Extended Data Fig. 2d ). We also observed induction of other intestinal LXR target genes including inducible degrader of LDLR (Idol, Mylip1) 8 (Extended Data Fig. 2d ). There was increased incorporation of [ 3 H]cholesterol into HDL-sized particles secreted from T39 −/− enterocytes isolated from chow-(Extended Data Fig. 2f ) and HF/HC/BS-dietfed mice (Extended Data Fig. 2g ). On the chow diet, enterocyte-specific T39 deletion in Villin-Cre + T39 fl/fl mice raised HDL cholesterol, whereas hepatocyte-specific T39 deletion in Albumin-Cre + T39 fl/fl mice had no effect, confirming the intestinal contribution to increased HDL (Fig. 1b ). T39 deficiency did not yield any difference in HDL cholesterol on the Lxrα −/− background (data not shown). Together, these findings suggest that the major mechanism responsible for increased HDL levels in chow-fed T39 −/− mice is increased intestinal expression of Abca1, secondary to a post-transcriptional induction of LXR protein. Hepatocyte T39 deficiency did, however, increase HDL cholesterol in mice fed the HF/HC/BS diet (Fig. 1b) , which was reversed by LXRα deficiency (data not shown). This suggests that under inflammatory conditions induced by the HF/HC/BS diet, the liver also contributes to the HDL phenotype of T39 −/− mice, consistent with the previous report that T39 knockdown mediated by adenovirus, which targets the liver and is inflammatory, raised HDL 2 .
HF/HC/BS diets have been used as a model of steatohepatitis resembling human non-alcoholic steatohepatitis 9 . After 20 weeks of HF/HC/ BS feeding, we noticed a fourfold reduction in mortality among T39 −/− mice (P < 0.05) ( Fig. 1c) , accompanied by decreased circulating alanine aminotransferase (ALT) levels (Extended Data Fig. 3a ). Livers were smaller and less pale in the T39 −/− mice than controls (Extended Letter reSeArCH Data Fig. 3b ), while there were no differences in body weight or gonadal fat pad weight (data not shown). The livers of T39 −/− mice had less Oil Red O staining (Fig. 1d ), reflecting diminished hepatic triglyceride (Extended Data Fig. 3c ) and cholesteryl ester (Extended Data Fig. 3d ) accumulation, fewer inflammatory foci consisting of neutrophils and lymphocytes ( Fig. 1e and Extended Data Fig. 3e ), less hepatocellular ballooning degeneration ( Fig. 1e and Extended Data Fig. 3f ), and less hepatocyte proliferation in T39 −/− mice (Extended Data Fig. 3g ). Mortality studies in tissue-specific T39 knockout mice revealed that protection was entirely due to hepatic T39 deficiency ( Fig. 1f ). The livers of Albumin-Cre + T39 fl/fl mice had less perisinusoidal and periportal fibrosis than the T39 fl/fl and Villin-Cre + T39 fl/fl mice ( Fig. 1g and Extended Data Fig. 4a, b ), reduced inflammation (Extended Data Fig. 4a , c), and less hepatocellular ballooning (Extended Data Fig. 4a, d ). In the livers of T39 −/− mice fed HC/HF/BS for 6 weeks, many LXR targets were upregulated, including Abcg5/8, stearoyl coenzyme A desaturase 1 (Scd1), elongation of very long chain fatty acids protein 5 (Elovl5), insulin induced gene 2a (Insig2a), and lysophatidylcholine acyltransferase 3 (Lpcat3, Mboat5) 10 , and these increases were reversed in Lxrα −/− T39 −/− mice ( Fig. 2a ). However, expression of lipogenic genes Srebf1 and fatty acid synthase (Fasn) was unchanged ( Fig. 2a ). There was no difference in LXRα protein expression between WT and T39 −/− mice fed chow ( Fig. 2b ). However, whereas feeding a HF/HC/BS diet reduced hepatic LXRα protein levels in WT mice, LXR protein levels in T39 −/− livers were largely preserved ( Fig. 2b , c), without any difference in Lxrα mRNA level (Extended Data Fig. 5a ). Similar mRNA levels of sulfotransferase 2b1 (Sult2b1) and Abcc1 were found in livers from both genotypes, suggesting that decreased LXR ligand sulfation and export 11 did not account for increased LXR target gene expression in T39 −/− mice (data not shown). Also, hepatic levels of natural LXR ligands, including 24S-, 25-, 27-hydroxycholesterol and desmosterol, were decreased in whole-body (Extended Data Fig. 5b ) and unchanged in hepatocytespecific T39 knockout mice (Extended Data Fig. 5c ). Thus, increased hepatic expression of LXR target genes in T39 −/− mice ( Fig. 2a ) was primarily due to a post-transcriptional increase in LXR protein.
Differences in serum ALT levels were abrogated in mice lacking LXRα ( Fig. 2d ), indicating that LXR activation is critical to the hepatoprotective effects of T39 deficiency. T39 −/− mice had decreased dietary cholesterol absorption ( Fig. 2e ), consistent with observations that hepatic and intestinal LXRα activation have been shown to decrease dietary cholesterol absorption 12, 13 . There was also delayed postprandial plasma triglyceride accumulation in T39 −/− mice ( Fig. 2f ). Reduced cholesterol absorption was LXRαdependent (Extended Data Fig. 5d ), and associated with reduced accumulation of exogenously derived hepatotoxic oxysterols such as 7β -hydroxycholesterol, and 7-ketocholesterol (Extended Data Fig. 5b ). The decrease in cholesterol absorption was not associated with a change in intestinal Niemann-Pick C1 like 1 (Npc1l1) expression (Extended Data Fig. 5e ) and persisted in the presence of the NPC1L1 inhibitor ezetimibe ( Fig. 2e ), suggesting that these changes are attributable to upregulation of the sterol exporters ABCG5/8 ( Fig. 2a ), which reduces fractional cholesterol absorption 14 . Consistent with ABCG5/8 induction 14 , hepatic concentrations of the plant sterol campesterol were lower in T39 −/− mice (Extended Data Fig. 5f ), and there was enhanced reverse cholesterol transport (Extended Data Fig. 5g ). While the decrease in sterol absorption could contribute to liver protection, both Albumin-Cre + T39 fl/fl and Villin-Cre + T39 fl/fl mice exhibited significantly decreased cholesterol absorption (Extended Data Fig. 5h ), whereas only the liver knockout was protective ( Fig. 1f ), suggesting there must be another mechanism contributing to the hepatoprotective effect of T39 deficiency. LXR activation by synthetic agonists has traditionally been associated with hypertriglyceridemia and hepatic steatosis, owing to induction of SREBP-1c, the transcription factor that controls lipogenic gene expression 15 . However, in enterocytes and livers of T39 −/− mice, Srebf1 mRNA and precursor protein were not induced (Extended Data Fig. 2d and Fig. 2a, b ). Notably, there was a dramatic inhibition of SREBP-1 processing to the smaller, transcriptionally active form in the livers of T39 −/− mice fed the HF/HC/BS diet (Fig. 2b ). The processing of SREBP-2, the transcription factor that regulates cholesterogenesis, was not affected (Extended Data Fig. 6a ). The decrease in the mature form of SREBP-1 associated with T39 deficiency was LXRα dependent (Extended Data Fig. 6b ). T39 −/− mice fed the Western-type diet (WTD) also had reduced hepatic triglyceride (Extended Data Fig. 6c ) and cholesterol (Extended Data Fig. 6d ) accumulation, and inhibition of SREBP-1 processing (Extended Data Fig. 6e ). Potentially contributing to decreased SREBP-1 processing, in the fasting state, there was marked LXRα -dependent induction of Insig2a ( Fig. 2a ), the polytopic protein that retains SREBP cleavage-activating protein (SCAP) and therefore SREBP in the endoplasmic reticulum, thereby preventing SREBP proteolytic cleavage. However, Insig2a is only induced by LXR in the absence of insulin 16 , while SREBP-1 activation is prominent in the postprandial state when insulin levels are elevated, suggesting there must be a separate, more physiologically relevant mechanism regulating SREBP-1 maturation.
In a fasting-refeeding experiment, WTD-fed T39 −/− mice displayed significantly decreased hepatic triglyceride synthesis in vivo (Fig. 3a) . The reduction in triglyceride synthesis was accompanied by decreased expression of many lipogenic genes, including Scd1, Elovl5, acetyl-CoA carboxylase α (Accα), glycerol-3-phosphate acyltransferase (Gpat1, Gpam), and glucose-6-phosphate dehydrogenase (G6pd), as well as patatin-like phospholipase domain-containing protein 3 (Pnpla3, adiponutrin), which is an SREBP-1 target implicated in human hepatic Letter reSeArCH steatosis 17, 18 (Fig. 3b ). Albumin-Cre + T39 fl/fl mice also had significant reductions in postprandial hepatic lipogenic gene expression (Extended Data Fig. 6f ). Since exogenous free fatty acids are the major source of hepatic triglyceride in mice fed a high fat diet 19 , the decrease in [ 3 H] triglyceride observed in Fig. 3d is probably due to lower rates of esterification of exogenous FA, possibly because of decreased hepatic Gpat1 expression ( Fig. 3b ) and delayed dietary triglyceride absorption ( Fig. 2f ). Hepatic insulin sensitivity did not differ between T39 −/− and WT mice, as glucose tolerance (Extended Data Fig. 6g ), hepatic gluconeogenesis (Extended Data Fig. 6h ), and insulin-induced Akt phosphorylation were similar in WT and T39 −/− mice (Extended Data Fig. 6i ).
Microsomal lipid composition changes could have a sustained effect on SREBP-1 processing in the fed state. Among the most significant changes in the membrane lipids was a 30% increase in phosphatidylcholine content in T39 −/− mice, with no differences in phosphatidylethanolamine and phosphatidylserine (data not shown). The increased in phosphatidylcholine may be attributable to LXRα -dependent upregulation of the Kennedy pathway enzymes, phosphate cytidyltransferase 1a (Pcyt1a) and choline/ethanolamine phosphotransferase 1 (Cept1) ( Fig. 2a ). Enzymes involved in an alternative methylation-dependent phosphatidylcholine synthesis pathway were not changed ( Fig. 2a ). Phosphatidylcholine synthesis is an important regulator of SREBP-1 proteolytic maturation in the liver 20 . In the endoplasmic reticulum, LPCAT3-mediated phospholipid remodelling preferentially acylates the sn-2 position of lysophosphatidylcholine, lysophosphatidylethanolamine, and lysophosphatidylserine with polyunsaturated fatty acids (PUFAs) 21 . There was a decreased ratio of lysophosphatidylcholine to phosphatidylcholine (Fig. 3c ), and phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine phosphatidylserine species all had significantly increased PUFA content ( Fig. 3d-f ), consistent with Lpcat3 upregulation 22 . PUFAs have been demonstrated to inhibit the transcription and processing of SREBP-1c 23 . Also, LPCAT3 activity ameliorates endoplasmic reticulum stress 10 , which affects SREBP-1 processing 24 . Together these data suggest that an LXRα -dependent increase in phosphatidylcholine synthesis and incorporation of PUFA into multiple phospholipid species in T39 −/− mice may be a major factor inhibiting the development of non-alcoholic fatty liver disease.
T39 −/− mice were crossed into the Ldlr −/− background and fed a WTD to determine whether the anti-atherogenic effects of LXR activation were maintained. Male Ldlr −/− T39 −/− mice had significantly lower total cholesterol and higher HDL cholesterol (Extended Data Fig. 7a ). Male and female Ldlr −/− T39 −/− mice both showed a reduction in LDL cholesterol (Extended Data Fig. 7a, b ), but plasma triglyceride levels were not different (data not shown). Atherosclerotic lesion area evaluated by en face Oil Red O staining of the aorta was significantly reduced in Ldlr −/− T39 −/− mice compared with Ldlr −/− controls (Fig. 3g) . Although there was no difference in overall lesion area in the proximal aorta (Extended Data Fig. 7c ), atherosclerosis was less advanced as judged by reduced lesion complexity in Ldlr −/− T39 −/− mice (Extended Data Fig. 7d ). Thus, T39 deficiency confers protection from atherosclerosis and fatty liver following challenge with the WTD.
In contrast to the liver, in cultured primary hepatocytes from chow-fed T39 −/− mice, the mRNA levels of LXR target genes (Srebf1, Scd1, Abcg5, and Abcg8) were increased, while expression of Lxrα and Lxrβ were unchanged (Fig. 4a ). LXRα protein was increased in the cytosol and nucleus of T39 −/− hepatocytes (Extended Data Fig. 8a ). We used the obligate heterodimer partner of LXR, retinoid X receptor (RXR) as a surrogate for the presence of LXR over LXR response elements (LXREs). There seemed to be increased occupancy by LXR/RXR over LXREs of several LXR targets both in the basal state and after GW3965 treatment in T39 −/− compared with WT hepatocytes (Extended Data Fig. 8b ). In co-overexpression studies, LXRα co-immunoprecipiated with T39 regardless of the epitope tag size (Fig. 4b) , indicating that LXRα and T39 coexist in the same protein complex. We discovered that endogenous LXR could be isolated using immobilized GW3965 (Extended Data Fig. 8c ). In mice treated with a proteasome inhibitor, there was significantly less polyubiquitinated LXRα relative to unmodified LXRα in T39-deficient livers (Fig. 4c ). There was a significantly slower rate of LXRα turnover in T39 −/− than WT hepatocytes ( Fig. 4d ). While the proteasome inhibitor bortezomib increased LXR in WT hepatocytes, it had no effect in T39 −/− hepatocytes (Fig. 4d ). These data suggest that T39 facilitates LXRα polyubiquitination and turnover, and that, in T39 −/− cells, LXRα is protected from proteasomal degradation. We found a significant inverse correlation between published data on LXRα binding strength to active regulatory elements in the liver 25 and the magnitude of target gene induction in T39 deficiency relative to WT (Extended Data Fig. 8d ), suggesting that the impact of increased LXR protein levels is larger for genes containing lower-affinity LXR binding sites, such as Insig2a and Lpcat3, and minimally affects genes containing high-affinity LXR binding sites, including Srebf1 and Fasn. Hepatic LXR overexpression has been reported to upregulate cholesterol removal genes such as Abcg5/8 (ref. 26), which is consistent with our findings. However, there were minimal effects on SREBP-1 target genes 26 , suggesting that decreased LXR ubiquitination may also contribute to the decreased lipogenesis in T39 −/− mice.
The deficiency of T39 demonstrates that, as opposed to the effects of potent synthetic ligands, decreasing the ubiquitination and increasing the abundance of endogenous LXR protein can activate anti-atherogenic cholesterol removal while inhibiting the lipogenesis that leads to steatosis (Extended Data Fig. 9 ). By ameliorating cardiovascular disease and non-alcoholic fatty liver disease, T39 inhibition could offer a new therapeutic approach to tackle two globally prevalent chronic diseases. Supplementary Fig. 1 for gel source data. 
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MethODS Mice and diet. Both male and female 10-to 20-week-old littermate mice were used in this study, and mice were allocated to experiments to match age and sex. T39 −/− mice on the C57Bl/6N background were obtained from the Wellcome Trust Sanger Institute (Hinxton, UK). Ldlr −/− T39 −/− mice were generated by crossing these mice with Ldlr −/− mice from Jackson Laboratory (Bar Harbour, Maine). LXRα −/− T39 −/− mice were generated by crossing T39 −/− mice with LXRα −/− mice from Jackson Laboratory. For all backgrounds, T39 +/+ and T39 −/− mice were generated by breeding T39 +/− mice. Tissue-specific T39 knockout mice were generated by crossing T39 fl/fl mice from Merck/TaconicArtemis (Germany) with Villin-Cre and Albumin-Cre mice obtained from the Jackson Laboratory. At 8 weeks of age, mice were started on either non-irradiated HF/HC/BS diet (7.5% cocoa butter, 1.25% cholesterol, 0.5% sodium cholate, no. 88051) or irradiated WTD (21% milk fat, 0.15% cholesterol, no. 88137) (Harlan Teklad). Mice were housed in a specific pathogen-free facility on a 12h:12h light:dark cycle. Compatible mice of mixed genotypes were housed in groups of five. Each mouse was assigned a unique identification number that did not indicate genotype, and experiments and measurements were conducted in a blinded manner until data analysis. Animal numbers were selected on the basis of power calculations of 0.8 using variances from previous studies and availability of genotypes that arose from heterozygote breedings. Protocols were approved by the Institutional Animal Care and Use Committee of Columbia University. Lipoprotein analysis. For chow and HF/HC/BS diet-fed samples, HDL cholesterol was determined in the supernatant of phosphotungstate/Mg 2+ -precipitated serum using an enzymatic-based colorimetric assay (Wako). Enzymatic-based colorimetric assays were also used to determine total serum cholesterol (Wako) and triglyceride (Infinity Triglycerides, Thermo Scientific). For WTD-fed Ldlr −/− mice, lipoproteins were separated by KBr density ultracentrifugation and then assayed using the above kits. Enterocyte collection, protein extraction, and western blotting. Enterocytes were collected from the jejunum using Cell Recovery Solution (BD) in a method adapted from Perreault & Beaulieu 27 . Enterocytes and liver samples were homogenized in 1% Triton X-100, 0.5% sodium deoxycholate, 2 mM EDTA, and 1 mM EGTA in phosphate buffered saline, pH 7.4. Cytoplasmic and nuclear fractions were extracted from hepatocytes using the CelLytic NuCLEAR Extraction kit (Sigma-Aldrich) according to the manufacturer's instructions. Proteins were resolved by SDS-PAGE and transferred to a polyvinylidene fluoride membrane for western blotting. Western blotting antibodies were rabbit anti-LXRα /β (H-144, Santa Cruz Biotechnology), mouse anti-LXRα (PPZ0412, Abcam), rabbit anti-ABCA1 (NB400-105, Novus Biologicals), mouse anti-SREBP-1 (clone 2A4, Thermo Scientific), rabbit anti-HSP90 (C45G5, Cell Signaling), goat anti-histone H3 (ab12079, Abcam), mouse anti-polyubiquitinated proteins (clone FK2, Millipore), and rabbit anti-SREBP-2 (14508-1-AP, Proteintech Group). An affinity-purified antibody against mouse and human T39 was generated by immunizing rabbits for 118 days against a conjugated amino-acid sequence of T39, NH 2 -CKESKWSKATYVFLKAAILS-COOH (Covance). The integrated density value of immunoblot signals was quantified by AlphaEaseFC software (Alpha Innotech).
Secretion of [ 3 H]cholesterol by primary enterocytes.
For characterization of secreted lipoproteins, enterocytes were isolated from overnight fasted mice, and radiolabelled for 1 h with 0.5 μ Ci/ml of [ 3 H]cholesterol, washed, and incubated with fresh media containing lipid/bile salt micelles consisting of 1.4 mM oleic acid, 0.14 mM sodium cholate, 0.15 mM sodium deoxycholate, 0.17 mM phosphatidylcholine, and 0.19 mM mono-oleoylglycerol 28, 29 . After 2 h, enterocytes were centrifuged and supernatants were collected. Media were subjected to density gradient ultracentrifugation to determine radiolabelled cholesterol distribution among lipoprotein classes 29 . Grading of non-alcoholic steatohepatitis. Frozen sections of liver were stained with haematoxylin and eosin. Livers from mice fed HF/HC/BS diet were assessed by a blinded observer at 200× magnification according to the staging outlined by Kleiner et al. 30 . The lobular inflammation grade was assigned a score from 0 to 3 as follows: no foci = 0; fewer than two foci per field = 1; two to four foci per field = 2; more than four foci per field = 3. Liver cell injury was assigned a score from 0 to 2 as follows: no ballooned cells = 0; a few ballooned cells = 1; many ballooned cells = 2; majority of hepatocytes are ballooned = 3. The fibrosis grade was assigned a score from 0 to 3 as follows: no fibrosis = 0; scattered centrilobular and perisinusoidal areas of fibrosis = 1; many regions of fibrosis and true bridging = 2; extensive fibrosis and bridging, with/without cirrhosis = 3. Dietary cholesterol absorption. Mice were fasted for 14 h and then given an intraperitoneal injection of Poloxamer-407 (1,000 mg/kg, Sigma-Aldrich) to inhibit peripheral triglyceride-rich lipoprotein catabolism. The mice were administered 10 μ Ci [ 3 H]cholesterol (PerkinElmer) in 135 μ L olive oil containing 0.1 mg cold cholesterol, and blood was sampled from the tail vein every 4 h. To inhibit NPC1L1, mice were gavaged with ezetimibe (10 mg/kg, Selleckchem) once daily for 3 days before the experiment. Sterol analysis and GC-MS analysis. Oxysterols were measured as previously described 31 . 19-Hydroxycholesterol (Steraloids) was added to samples as an internal standard. Lipids were extracted from plasma (50 μ l) or livers (50 mg wet weight) with chloroform/methanol/water (1:2:0.8, v/v) containing butylated hydroxytoluene according to the Bligh and Dyer method 32 . Then the lipids were saponified at room temperature overnight in the dark. Unsaponified lipid was applied to a Sep-Pak Vac silica cartridge (Waters) to separate oxysterols and sterols 33 . Trimethylsilyl derivatives of the sterols were quantified by gas chromatography-mass spectrometry using a GC/MS QP2010 (Shimadzu) equipped with a SPB-1 fused silica capillary column (60 m × 0.25 mm × 0.25 μ m; Spelco). In the oven temperature programme, the temperature was initiated at 180 °C for 1 min and then raised to 250 °C at 20 °C/min and to 290 °C at 5 °C/min then held for 45 min. The injection temperature was set at 300 °C, the interface at 300 °C, and the ion source adjusted to 200 °C. In vivo determination of de novo lipogenesis. WTD-fed mice were fasted overnight and then refed for 4 h. Mice were given an intraperitoneal injection of 1.5 mCi [ 3 H]water, and the liver was harvested 2 h later. Hepatic lipids were extracted by the Folch method and resolved by thin layer chromatography. The lipid spots visualized by iodine were scraped and 3 H incorporation was determined by liquid scintillation counting. Biosynthetic rate was calculated essentially as described previously by Spady and Dietschy 34 . Lipidomics analysis. Microsomes were isolated from livers from HF/HC/BS diet-fed mice. Briefly, livers were homogenized with a Dounce homogenizer in a KCl-sucrose buffer (0.05 M KH 2 PO 4 , 0.25 M sucrose, 0.154 M KCl, pH 7.5) supplemented with protease inhibitors. Cellular debris, mitochondria, nuclei and plasma membrane were removed with a 10,000g centrifugation, and microsomes were pelleted with a 100,000g ultracentrifugation. Lipids were extracted by the Folch method in chloroform:methanol supplemented with butylated hydroxytoluene. Lipid extracts of purified microsome were spiked with a cocktail of internal standards, and analysed using a 6490 Triple Quadrupole LC/MS system (Agilent Technologies). Glycerophospholipids and sphingolipids were separated with normal-phase HPLC as described before 35 , with a few modifications. A Zorbax Rx-Sil column (inner diameter 2.1 mm × 100 mm, Agilent) was used under the following conditions: mobile phase A (chloroform:methanol:1 M ammonium hydroxide, 89.9:10:0.1, v/v) and mobile phase B (chloroform:methanol:water: ammonium hydroxide, 55:39.9:5:0.1, v/v); 95% A for 2 min, linear gradient to 30% A over 18 min and held for 3 min, and linear gradient to 95% A over 2 min and held for 6 min. Quantification of lipid species was accomplished using multiple reaction monitoring transitions and instrument settings that were determined in earlier studies 35 in conjunction with referencing of known amounts of internal standards: phosphatidic acid 14:0/14:0, phosphatidylcholine 14:0/14:0, phosphatidylethanolamine 14:0/14:0, phosphatidylinositol 12:0/13:0, phosphatidylserine 14:0/14:0, sphingomyelin d18:1/12:0 (Avanti Polar Lipids). Atherosclerosis study. Ldlr −/− and Ldlr −/− , T39 −/− mice were fed WTD for 20 weeks. Mice were killed in accordance to the American Veterinary Association Panel. Hearts and aortas were perfused with phosphate buffered saline, isolated and fixed in neutral phosphate-buffered formalin. The aortic arch and the descending aorta were stained with Oil Red O. Aortas were pinned on silicon dishes and Oil Red O positive areas were quantified using Image J software and expressed as the percentage of the total aorta area. Hearts were dehydrated, embedded in paraffin, and the aortic root area was cross-sectioned in 5 μ m sections. The sections were stained with haematoxylin and eosin and the average of six evenly distributed sections for each animal was used to determine lesion size and complexity. Lesion size was quantified by morphometric analysis using Image-Pro Plus software (Media Cybernetics). The typing of lesions is done according to the typing for humans proposed by the American Heart Association 36 and adapted to categorize murine lesions 37 . In this study, we discerned sections showing macrophage foam cell rich lesions (type I-II), complex lesions with fibrous caps (type III), and advanced lesions with foam cells in the media and presence of fibrosis, cholesterol clefts, mineralization and/or necrosis (type IV-V). Plasmids. Human T39 was cloned from HepG2 cDNA into pCMV6-AN-GFP, pCMV6-Entry, and pCMV6-AN-Myc-DDK vectors (Origene) linearized by SgfI and MluI digestion using the In-Fusion PCR cloning kit (Clontech). Using the same approach, murine Nr1h3 cDNA in the pCMV-SPORT6 vector (DF/HCC DNA Resource Core, Harvard University) was subcloned into the pCMV6-Entry and pCMV6-AN-Myc-DDK vectors. Primary hepatocyte culture and transfection. Hepatocytes were isolated from 6-to 12-week-old littermate mice using the two-step perfusion method and seeded onto collagen I-coated dishes (BD Biocoat) at a density of 2.5 × 10 4 cells/cm 2 in DMEM (Cellgro) containing 10% fetal bovine serum (Gibco) and 1% penicillin/ streptomycin (Gibco). Cells were crosslinked and harvested for chromatin immunoprecipitation analysis 2 h following hepatocyte isolation. Hepatocytes were transfected the following day using JetPEI-Gal (Polyplus) according to the manufacturer's instructions and experiments were performed 3 days after transfection. Cell culture and transfection. HEK293T cells (ATCC) were propagated in DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were not tested for mycoplasma contamination after receipt from the ATCC. Chromatin immunoprecipitation. Mouse hepatocytes were harvested and cultured as described above. At the time of plating, hepatocytes were treated with either DMSO or 2 μ M GW3965. Two hours after treatment, hepatocytes were crosslinked in 1% formaldehyde, at room temperature, for 10 or 20 min (depending on IP). The cross-linking reaction was quenched using 0.125 M glycine (10 min at room temperature). Cells were washed twice with cold PBS, then scraped in cold PBS and pelleted at 3,000 r.p.m. The pellet was then resuspended in 1% SDS sonication buffer (50 mM Tris-HCl pH 8.0, 10mM EDTA) and sonicated using a Fisher Scientific 550 Sonic Dismembrator. Using a cycle setting of 7, lysates were sonicated for 15 s followed by a 30 s rest; two sets of six pulses were performed to acquire sheared DNA between 200 and 1,000 bp. Lysates were then cleared at 14,000 r.p.m. for 10 min at 4 °C; 500 μ g of chromatin was used for each IP. Antibodies used for chromatin immunoprecipitation: anti-RXR (Δ N 197, Santa Cruz Biotechnology) and Rabbit IgG (sc2027, Santa Cruz Biotechnology). Primers for chromatin immunoprecipitation analysis were designed according to LXREs identified by ChipSeq 25 . Isolation of endogenous LXR with GW3965-affinity beads. Female mice fed HF/HC/BS diet were fed HF/HC/BS diet for 6 weeks, and infected with CMV-Ubc adenovirus (Vector Biolabs) during the last week. Mice were given an oral gavage of the proteasomal inhibitor ixazomib (20 mg/kg in 40% 2-hydroxypropyl-βcyclodextrin, Selleckchem) and then fasted for 6 h before being killed. GW3965 HCl (Selleckchem) was coupled to M-270 amine Dynabeads (Invitrogen) in a nitrogen-purged reaction containing N-(3-dimethylaminopropyl)-N′ethylcarbodiimide, 4-(dimethylamino)pyridine, and tributylamine in dimethylformamide (Sigma). Replacing the carboxylic acid in GW3965 with an amide in the coupling reaction allows the synthetic LXR agonist to retain its ligand binding domain recruitment activity 38 . Livers from HF/HC/BS diet-fed mice were sonicated in HEPES lysis buffer (50 mM HEPES, 150 mM NaCl, 1% NP-40, 10% glycerol, 5 mM EDTA, pH 7,4) supplemented with 10 mM N-ethylmaleimide, 10 mM iodoacetamide (Sigma), 25 μ M PR-619 (Calbiochem), 5 μ M MG-132 (Selleckchem), TUBE-2 (LifeSensors), and Halt Protease Inhibitor Cocktail (Thermo Scientific). Liver lysates were incubated with GW3965-beads at 37 °C for 2 h. LXRα protein turnover. Flag-Myc-LXRα -transfected primary hepatocytes were cultured in methionine-free media for 1 h, and then protein synthesis was labelled with 400 μ M L-homopropargylglycine (HPG) for 30 min. The labelled primary hepatocytes were washed and then cultured in 20 mM l-methionine-enriched media with/without bortezomib for the duration of the chase. Flag-Myc-LXRα was immunoprecipitated with anti-Flag (clone M2)-conjugated magnetic beads (Sigma-Aldrich) and HPG-labelled proteins were conjugated to tetramethylrhodamine azide by click chemistry (Molecular Probes) before separation by SDS-PAGE for visualization. Statistical analysis. No statistical methods were used to predetermine sample size. The experiments were not randomized. All data are represented as mean ± s.e.m. and, unless otherwise stated, were analysed using a two-tailed Student's t-test or two-way ANOVA with Bonferroni post hoc analysis where appropriate. In experiments where n ≥ 8 for all genotypes, the D' Agostino-Pearson omnibus test for normality and Bartlett's test for variance were used to ensure that the assumptions of the statistical tests were met. All tests were performed with Prism (Graphpad) and P < 0.05 was considered statistically significant. Values/animals were excluded if it was detected as a significant (P < 0.05) outlier on the basis of a two-sided Grubbs' test. are represented as mean ± s.e.m., * P < 0.05, * * * P < 0.001 by two-tailed Student's t-test. d, Lesion severity as graded by a blinded observer on six sections per animal, n = 5 per genotype per gender. Lesion severity is expressed as number of observations of each complexity category and the difference in the categorical distribution of lesions between the two groups is indicated, * P < 0.05 based on a χ 2 -test.
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